Edition:
United States

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

2.02USD
7 Dec 2018
Change (% chg)

$-0.01 (-0.49%)
Prev Close
$2.03
Open
$2.03
Day's High
$2.07
Day's Low
$1.96
Volume
301,150
Avg. Vol
452,801
52-wk High
$3.58
52-wk Low
$1.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.47 -0.184
Jun '18 0.43 0.031
Mar '18 1.03 -0.076
FY 2017 Dec '17 0.08 0.030
Sep '17 4.61 -0.224
Jun '17 0.35 -0.301
Mar '17 2.53 -0.116
FY 2016 Dec '16 0.13 -0.074
Sep '16 0.99 -0.065
Jun '16 0.19 -0.129
Mar '16 1.20 -0.133
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 2.45 2.76 2.15 3.43
Quarter Ending Mar-19 2 1.00 1.00 1.00 --
Year Ending Dec-18 2 5.51 6.08 4.95 11.79
Year Ending Dec-19 2 7.94 10.88 5.00 18.55
Earnings (per share)
Quarter Ending Dec-18 2 -0.06 -0.05 -0.07 -0.07
Quarter Ending Mar-19 2 -0.09 -0.06 -0.11 --
Year Ending Dec-18 2 -0.23 -0.16 -0.31 -0.36
Year Ending Dec-19 2 -0.35 -0.21 -0.50 -0.37
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 1.22 0.91 0.90
Price to Sales (TTM) 113.52 116.41 5.77
Price to Book (MRQ) -- 15.60 5.12
Price to Tangible Book (MRQ) -- 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 55.19 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 81.87 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -80.14 90.38 5.80
Sales - 5 Yr. Growth Rate -56.68 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -134.12 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -136.08 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -69.44 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 2.82 5.42 3.11
LT Debt to Equity (MRQ) -- 33.58 11.47
Total Debt to Equity (MRQ) -- 35.41 15.63
Interest Coverage (TTM) -4.32 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -788.96 -- --
EBITD - 5 Yr. Avg -429.91 -506.71 11.83
Operating Margin (TTM) -789.53 -728.63 4.90
Operating Margin - 5 Yr. Avg. -510.96 -526.19 7.44
Pre-Tax Margin (TTM) -1,315.52 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -524.47 -531.06 7.89
Net Profit Margin (TTM) -1,316.79 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -524.64 -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 200,100 25,687,363 898,926,015
Net Income/Employee (TTM) -2,634,900 2,194,067 106,550,787
Receivable Turnover (TTM) 4.58 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.09 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -123.74 -1.11 11.50
Return on Assets - 5 Yr. Avg. -50.47 2.88 12.67
Return on Investment (TTM) -166.61 0.28 15.02
Return on Investment - 5 Yr. Avg. -65.79 1.84 16.45
Return on Equity (TTM) -- 0.94 16.60
Return on Equity - 5 Yr. Avg. -93.64 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -86.78 24.83 -56.68
EPS (TTM) % -44.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aveo Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.05 -2.43 91 57
13 Week 37.63 30.93 99 62
26 Week 553.06 503.42 99 81
52 Week 346.56 278.50 99 47
YTD 611.11 524.50 99 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.13%
# of Holders: 130
Total Shares Held: 54,065,696
3 Mo. Net Change: -9,879,773
# New Positions: 21
# Closed Positions: 17
# Increased Positions: 68
# Reduced Positions: 43
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.